Johnson & Johnson has announced a new initiative in the United Arab Emirates aimed at supporting access to liquid biopsy testing for patients diagnosed with metastatic non-small cell lung cancer (NSCLC).
CE-Ventures, the corporate venture capital arm of Crescent Enterprises, on Tuesday announced that its portfolio company CrossBridge Bio has entered into a definitive agreement to be acquired by US pharmaceutical major Eli Lilly and Company.
Qiddiya Investment Company has signed an agreement with King Faisal Specialist Hospital and Research Centre (KFSH) for joint collaboration on the establishment of a premium facility in Riyadh that will deliver specialised sports medicine services in line with international standards.
The Women's Pavilion at Expo City Dubai, in partnership with Meem Foundation, American Hospital Dubai and PeriCare, has launched Her Health Majlis – an ongoing wellness series offering accessible, stigma-free education on women's health.
Researchers at NYU Abu Dhabi have developed smart molecules capable of both detecting and treating cancer, offering a safer and more precise approach to care. Farah Benyettou, lead researcher, and Thirumurugan Prakasam, a research scientist, were part of the team.
The installed renewable energy capacity has exceeded 7.7 gigawatts (GW), with projects under development expected to raise total capacity to more than 23 GW by 2031, a WAM news agency report said.
Emirates Drug Establishment (EDE) has approved Foundayo (orforglipron), an innovative oral treatment for chronic weight management, making the UAE the second country in the world to register the medication, developed by global pharmaceutical company Eli Lilly.
Abu Dhabi has taken a major step toward transforming how disease is detected, prevented and treated, with the inauguration of the Abu Dhabi Biobank, a platform that connects biological samples with genomic, lifestyle and clinical data to enable earlier action and more personalised care.
Eli Lilly and Company has announced that the US Food and Drug Administration (FDA) has approved Foundayo (orforglipron) for adults with obesity, or overweight with weight-related medical problems.
Kanoo Ventures, part of the Yusuf bin Ahmed Kanoo Group and a strategic investor in the specialised healthcare investment fund managed by Esterad Bank, has announced that its Chairman Nabeel Kanoo visited The Eye Infirmary’s main centre in the Seef District.
